• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.00% Nasdaq Up0.38%

    InSite Vision Incorporated (INSV)

    -Other OTC
    0.14 0.00(0.00%) May 21, 3:51PM EDT
    |Pre-Market : NaN
    Add to Portfolio
    ProfileGet Profile for:
    InSite Vision Incorporated
    965 Atlantic Avenue
    Alameda, CA 94501
    United States - Map
    Phone: 510-865-8800
    Fax: 510-865-5700
    Website: http://www.insitevision.com

    Index Membership:N/A
    Industry:Drug Delivery
    Full Time Employees:29

    Business Summary 

    InSite Vision Incorporated, an ophthalmic product development company, engages in developing ophthalmic pharmaceutical products to address unmet eye care needs in the United States. The company develops its products based on its proprietary DuraSite drug delivery technology. It offers AzaSite, a macrolide antibiotic for the treatment of bacterial conjunctivitis; and Besivance, a fluoroquinolone antibiotic for the treatment of bacterial conjunctivitis. The products under development include BromSite, which has completed Phase III clinical trials for the treatment of post-operative inflammation, as well as the prevention of post-operative eye pain; DexaSite, which has completed Phase III clinical trials for the treatment of ocular inflammation; and AzaSite Plus, a fixed combination of azithromycin and dexamethasone that is in Phase III clinical trials for the treatment of ocular inflammation and infection. It is also developing DuraSite 2, a next-generation enhanced drug delivery system, which is designed to provide a broad platform for developing ophthalmic therapeutics; and ISV-101, a DuraSite formulation with low concentration of bromfenac that is used for the treatment of dry eye diseases. The company has collaborative, licensing, and service agreements with Pfizer and Pfizer Products, Inc.; Akorn, Inc.; Catalent Pharma Solutions; and Bausch and Lomb Incorporated. InSite Vision Incorporated was founded in 1986 and is based in Alameda, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on InSite Vision Incorporated

    Key Executives 
    Mr. Timothy Ruane M.B.A., 50
    Chief Exec. Officer and Director
    Mr. Louis C. Drapeau B.S., M.B.A., 71
    Chief Financial Officer and VP
    Mr. Surendra I. Patel , 60
    VP of Operations and Quality
    Dr. Kamran Hosseini M.D., Ph.D., 50
    Chief Medical Officer, VP of Clinical & Regulatory Affairs and Member of Scientific Advisory Board
    Dr. Lyle M. Bowman Ph.D., 66
    VP of Devel. and Sec.
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders